Last reviewed · How we verify
NCT05032339
Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer
trial testing IUO Plasma Cell Disorders Panel in Plasma Cell Disorder in 208 participants. Completed in 25 October 2023.
25 October 2023
Quick facts
| Lead sponsor | Becton, Dickinson and Company |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 208 |
| Start date | 4 May 2021 |
| Primary completion | 25 October 2023 |
| Estimated completion | 25 October 2023 |
| Sites | 5 locations across United Kingdom, Switzerland, Portugal, United States, Spain |
Drugs / interventions tested
- IUO Plasma Cell Disorders Panel
Conditions studied
- Plasma Cell Disorder — all drugs for Plasma Cell Disorder →
Sponsor
Becton, Dickinson and Company — full company profile →
Who can join
22 and older, any sex, with Plasma Cell Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multi-site, prospective performance study to determine equivalency between the investigational OneFlow PCD panel on the FACSLyric system versus the final clinical diagnosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05032339
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Plasma Cell Disorder
Currently open trials in the same condition.
- NCT07075510 — Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders · Phase 1, PHASE2 · recruiting
- NCT03480360 — Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression · Phase 3 · active not recruiting
Other Becton, Dickinson and Company trials
Trials by the same sponsor.
- NCT06632509 — BD SiteRite(TM) 9 Ultrasound System - Clinical Study · completed
- NCT06632496 — BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study · completed
- NCT06604026 — Investigational Study With the BD PosiFlush™ SafeScrub on NADs · NA · recruiting
- NCT06426121 — Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product · completed
- NCT05953363 — Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05032339 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Becton, Dickinson and Company
- Last refreshed: 30 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05032339.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing